Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Health Solutions, Inc.    

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Catalyst Health Solutions, Inc. : Faruqi & Faruqi, LLP Announces Investigation of Catalyst Health Solutions, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
04/19/2012 | 01:05am CET

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Catalyst Health Solutions, Inc. ("Catalyst" or the "Company") (NASDAQ: CHSI) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to SXC Health Solutions Corp. ("SXC") (NASDAQ: SXCI, TSX: SXC) in a cash-and-stock transaction valued at approximately $4.4 billion. Under the terms of the merger agreement, Catalyst shareholders will receive $28.00 in cash and 0.6606 shares of SXC stock for each Catalyst share, which implies a purchase price of $81.02 per each share of Catalyst common stock based on the closing stock prices of SXC and Catalyst on April 17, 2012.

Request more information now by clicking here: www.faruqilaw.com/CHSI. There is no cost or obligation to you.

Whether Catalyst's Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Catalyst's shares and by how much this proposed transaction undervalues the Company to the detriment of Catalyst's shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients.

If you own common stock in Catalyst and wish to obtain additional information and protect your investment free of charge, please visit us at www.faruqilaw.com/CHSI or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Juan E. Monteverde, Esq.
[email protected]
Toll Free: (877) 247-4292
Phone: (212) 983-9330

© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
2012 U.S. HOT STOCK FUTURES : Hot stocks to watch
2012 CATALYST HEALTH SOLUTIONS, INC. : Catalyst Health Solutions Announces Stockholde..
2012 Humana Pharmacy Unit Seeks Customers Amid Industry Changes
2012 Express Scripts Strikes Bullish Tone As Selling Season Picks Up
2012 CATALYST HEALTH SOLUTIONS, INC. : HospiScript Named Pharmacy Benefits Manager fo..
2012 CATALYST HEALTH SOLUTIONS, INC. : Catalyst Health Solutions Reports First Quarte..
2012 CATALYST HEALTH SOLUTIONS, INC. : to Report First Quarter Financial Results on M..
2012 CATALYST HEALTH SOLUTIONS, INC. : Law Office of Brodsky & Smith, LLC Announces I..
2012 CATALYST HEALTH SOLUTIONS, INC. : Securities Lawyers at Goldfarb LLP Seeking Mor..
2012 CATALYST HEALTH SOLUTIONS, INC. : Catalyst Health Solutions Selected as Pharmacy..
More news
Sector and Competitors
1st jan.Capitalization (M$)
ANTHEM INC11.07%64 319
AETNA4.86%61 734
CIGNA8.28%54 189
HUMANA13.42%40 409